Venus Remedies - Quaterly Results

29 Oct 2024 Evaluate
Revenue showed a marginal decline at Rs. 1670.20 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.Profit for the quarter ended September 2024 rises by 69.91% to Rs. 92.60  millions from Rs. 54.50 millions.Operating profit surged to 209.80 millions from the corresponding previous quarter of 160.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1670.20 1701.90 -1.86 2728.80 2688.20 1.51 5752.10 5376.60 6.98
Other Income 107.10 29.30 265.53 122.70 49.90 145.89 113.20 101.70 11.31
PBIDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 209.80 160.60 30.64 368.20 315.90 16.56 722.00 717.00 0.70
Depreciation 61.70 62.10 -0.64 119.30 135.30 -11.83 255.50 313.70 -18.55
PBT 148.10 98.50 50.36 248.90 180.60 37.82 466.50 403.30 15.67
TAX 55.50 44.00 26.14 111.80 82.70 35.19 161.50 113.70 42.04
Deferred Tax 18.30 7.20 154.17 49.20 12.00 310.00 39.30 113.70 -65.44
PAT 92.60 54.50 69.91 137.10 97.90 40.04 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 12.56 9.44 33.12 13.49 11.75 14.82 12.55 13.34 -5.88

Venus Remedies Share Price

672.15 -12.40 (-1.81%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×